BioMarin News

Main menu
Contents

Want to see the real deal?
More inside scoop? View in App

My Company

#Polls

Browse by:

Companies

Keywords

Customize Interests

Blog

COMPANY

SUPPORT

Rooftop Slushie Get Referrals to FAANG

DOWNLOAD THE APP:

BioMarin

3.3 (6 reviews)

REVIEW THIS COMPANY

BioMarin Queen Anne and Mangolia News / May 4, 2022

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at the BofA Securities Healthcare Conference on May 12...

https://investors.biomarin.com/2022-05-04-BioMarin-to-Participate-in-the-BofA-Securities-2022-Healthcare-Conference,-Thursday,-May-12-at-8-40amPT-11-40amET

BioMarin to Participate in the BofA Securities 2022 Healthcare Conference, Thursday, May 12 at 8:40amPT/11:40amET

Queen Anne and Mangolia News

BioMarin Queen Anne and Mangolia News / May 4, 2022

″ Get Sample Report Buy Now Enzyme Replacement Therapy Market research report is the new statistical

https://www.magnolianews.net/Content/enzyme-replacement-therapy-market-scope-and-overview-to-develop-with-increased-global-emphasis-on-industrialization-2029-sanofi-takeda-biomarin/

Enzyme Replacement Therapy Market Scope and overview, To Develop with Increased Global Emphasis on Industrialization 2029 Sanofi, Takeda, BioMarin – Queen Anne and Mangolia News

Queen Anne and Mangolia News

BioMarin Ripon College Days / Apr 27, 2022

New Jersey, United States - The study is a professional and comprehensive assessment of the Lam

https://www.themobility.club/news/2022/04/27/lambert-eaton-myasthenic-syndrome-treatment-market-size-scope-and-outlook/

Lambert-Eaton Myasthenic Syndrome Treatment Market Size, Scope And Outlook | Jacobus Pharmaceutical Company, Zydus Cadila, BioMarin, Catalyst Pharma, Novartis AG, Shenox Pharmaceuticals, LLC, Amneal Pharmaceuticals LLC, Alvogen, Apnar phar

Ripon College Days

BioMarin Ripon College Days / Apr 27, 2022

New Jersey, United States - The study is a professional and comprehensive assessment of the Acq

https://www.riponcollegedays.com/acquired-hemophilia-treatment-market-size-scope-and-outlook/

Acquired Hemophilia Treatment Market Size, Scope And Outlook | Shire (Baxalta); CSL Behring; Pfizer, Inc.; Bayer AG; BioMarin, Spark Therapeutics, Inc.; Genzyme Corporation; Chugai Pharmaceutical Co. Ltd.; Novo Nordisk A/S.; and Octapharma AG. – Ripo

Ripon College Days

BioMarin Digital Journal / Apr 24, 2022

The study on global Hemophilia market, offers profound understandings about the Hemophilia market covering all the essential aspects of the market. The

https://www.digitaljournal.com/pr/game-on-hemophilia-industry-data-forecast-2028-by-baxalta-csl-behring-pfizer-inc-bayer-healthcare-biomarin-pharmaceutical-inc

Game on: Hemophilia Industry Data & Forecast 2028 by Baxalta, CSL Behring, Pfizer Inc.., Bayer Healthcare, BioMarin Pharmaceutical Inc..

Digital Journal

BioMarin BioSpace / Apr 22, 2022

BioMarin is looking to help inspire the next generation of filmmakers while creating a new documentary about hemophilia along the way. | First came “Hemophilia: The Musical.” Now, BioMarin is looking to inspire the next generation of filmmakers while creating a new documentary about the bleeding dis…

https://www.fiercepharma.com/marketing/biomarin-gets-filmmaking-plots-patient-documentary-new-bleeding-disorder-campaign

BioMarin plots hemophilia patient documentary

BioSpace

BioMarin BioSpace / Apr 22, 2022

The Global Lysosomal Storage Disorder Drugs Market is estimated to gain market growth in the upcoming forecasted years. An influential Lysosomal Storage

https://www.digitaljournal.com/pr/lysosomal-storage-disorder-drugs-market-may-see-a-big-move-by-2029-global-companies-like-pfizer-sanofi-biomarin-actelion

Lysosomal Storage Disorder Drugs Market May See a Big Move by 2029 | Global Companies like Pfizer, Sanofi, BioMarin, Actelion

BioSpace

BioMarin BioSpace / Apr 22, 2022

Global “Hemophilia Treatment Market Report” Research Report 2022 - 2028 contains a thorough examinat

https://www.irishemigrant.com/latest-update-hemophilia-treatment-market-2022-what-is-the-impact-of-covid-19-on-key-players-forecast-to-2028-csl-behring-baxalta-pfizer-inc-biomarin/

Latest Update: Hemophilia Treatment Market 2022, What Is the Impact of Covid 19 on Key Players, Forecast to 2028: CSL Behring, Baxalta, Pfizer Inc, BioMarin – The New York Irish Emgirant

BioSpace

BioMarin BioSpace / Apr 22, 2022

According to the latest research published by Future Market Insights, the global enzyme replacement therapy market is poised to expand at 6.7% CAGR over the forecast period 2022–2028. The global market for enzyme replacement therapy is expected to exceed US$ 13.8 Bn by the end of 2028, attesting...

https://www.pharmiweb.com/press-release/2022-04-22/enzyme-replacement-therapy-market-projected-a-total-valuation-of-us-138-bn-by-the-end-of-2028

Enzyme Replacement Therapy Market Projected a Total Valuation of US$ 13.8 Bn by the end of 2028

BioSpace

BioMarin BioSpace / Apr 22, 2022

New Jersey, United States - The Acquired Hemophilia Treatment Market report is the ultimate too

https://www.irishemigrant.com/acquired-hemophilia-treatment-market-size-and-forecast-to-2029/

Acquired Hemophilia Treatment Market Size, Scope And Forecast | Shire (Baxalta); CSL Behring; Pfizer, Inc.; Bayer AG; BioMarin, Spark Therapeutics, Inc.; Genzyme Corporation; Chugai Pharmaceutical Co. Ltd.; Novo Nordisk A/S.; and Octapharma AG. – The

BioSpace

BioMarin BioSpace / Apr 22, 2022

Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

https://www.biospace.com/article/biospace-movers-and-shakers-april-22/

Movers & Shakers: John Maraganore, Larry Alstiel, Brad Margus and More | BioSpace

BioSpace

BioMarin The New York Irish Emgirant / Apr 21, 2022

/PRNewswire/ -- On the heels of World Hemophilia Day, Believe Limited today announced a continuation of its exclusive partnership with BioMarin Pharmaceutical...

https://www.prnewswire.com/news-releases/believe-limited-continues-biomarin-partnership-on-breaking-through-programming-with-documentary-filmmaking-project-for-bleeding-disorder-community-301530470.html

Believe Limited Continues BioMarin Partnership on Breaking Through! Programming with Documentary Filmmaking Project for Bleeding Disorder Community

The New York Irish Emgirant

BioMarin The New York Irish Emgirant / Apr 21, 2022

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) CEO Jean Jacques Bienaime sold 20,000 shares of the business’s stock in a transaction on Monday, April 18th. The shares were sold at an average price of $81.91, for a total transaction of $1,638,200.00. Following the completion of the transacti…

https://www.defenseworld.net/2022/04/21/biomarin-pharmaceutical-inc-nasdaqbmrn-ceo-jean-jacques-bienaime-sells-20000-shares.html

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CEO Jean Jacques Bienaime Sells 20000 Shares

The New York Irish Emgirant

BioMarin The New York Irish Emgirant / Apr 21, 2022

If history is any guide, there may be trouble ahead for shares of Biomarin Pharmaceutical (NASDAQ:BMRN). A so-called “death cross” has formed on its chart and, not surprisingly, this could be bearish for the stock.

https://www.benzinga.com/markets/22/04/26740564/a-bearish-sign-appears-on-biomarin-pharmaceuticals-chart

A Bearish Sign Appears On Biomarin Pharmaceutical's Chart

The New York Irish Emgirant

BioMarin The New York Irish Emgirant / Apr 21, 2022

The Gaucher Disease Treatment Market Report Forcast to 2022-2028 offers an in-depth analysis of driv

https://www.irishemigrant.com/get-better-outlook-on-gaucher-disease-treatment-market-current-trends-and-key-players-who-were-successful-in-covid-19-pandemic-abbott-aptalis-pharma-genzyme-corporation-glaxosmithkline-gsk/

Get Better Outlook on Gaucher Disease Treatment Market Current Trends, and Key Players Who Were Successful in Covid 19 Pandemic: Abbott, Aptalis Pharma, Genzyme Corporation, GlaxoSmithKline (GSK) – The New York Irish Emgirant

The New York Irish Emgirant

BioMarin Clark County Blog / May 8, 2021

New Research: Global Duchenne Muscular Dystrophy Market 2026 Industry Specifications and Outlook 2021| PTC Therapeutics, Sarepta Therapeutics, Bristol-Myers Squibb, ITALFARMACO, BioMarin Brockville Observer

https://thebrockvilleobserver.ca/uncategorized/420/new-research-global-duchenne-muscular-dystrophy-market-2026-industry-specifications-and-outlook-2021-ptc-therapeutics-sarepta-therapeutics-bristol-myers-squibb-italfarmaco-biomarin/

New Research: Global Duchenne Muscular Dystrophy Market 2026 Industry Specifications and Outlook 2021| PTC Therapeutics, Sarepta Therapeutics, Bristol-Myers Squibb, ITALFARMACO, BioMarin

Clark County Blog

BioMarin Clark County Blog / May 8, 2021

Covid-19 impact on Hemophilia Treatment Market Future Outlook of Statistics on Industry Growth till 2026| CSL Behring, Baxalta, Pfizer Inc, BioMarin, Bayer Healthcare, Biogen – Clark County Blog Clark County Blog

https://clarkcountyblog.com/uncategorized/855172/covid-19-impact-on-hemophilia-treatment-market-future-outlook-of-statistics-on-industry-growth-till-2026-csl-behring-baxalta-pfizer-inc-biomarin-bayer-healthcare-biogen/

Covid-19 impact on Hemophilia Treatment Market Future Outlook of Statistics on Industry Growth till 2026| CSL Behring, Baxalta, Pfizer Inc, BioMarin, Bayer Healthcare, Biogen – Clark County Blog

Clark County Blog

BioMarin MarketBeat / May 5, 2021

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) EVP George Eric Davis sold 4,673 shares of the company's stock in a transaction that occurred on Monday, May 3rd. The shares were sold at an average price of $78.30, for a total transaction of $365,895.90. Following the sale, the executive vice president now owns 68,781 shares in the company, valued at $5,385,552.30.

https://www.marketbeat.com/instant-alerts/nasdaq-bmrn-insider-buying-and-selling-2021-05/

George Eric Davis Sells 4,673 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock

MarketBeat

BioMarin KSU | The Sentinel Newspaper / May 5, 2021

The Lipoid Proteinosis Drug Market research report analyzes the current as well as future aspects of the industry & presents leading regions, growth trends & strategies of the key players which is bound to impact the global Lipoid Proteinosis Drug industry share in various end-use applications.

https://ksusentinel.com/2021/05/05/lipoid-proteinosis-drug-market-to-register-a-strong-growth-rate-and-huge-profits/

Lipoid Proteinosis Drug Market To Register a Strong Growth Rate and Huge Profits – KSU | The Sentinel Newspaper

KSU | The Sentinel Newspaper

BioMarin KSU | The Sentinel Newspaper / May 5, 2021

The Global Oculopharyngeal Muscular Dystrophy (OPMD) market for the forecasting period of 2019-2028. The report is made out with a comprehensive analysis of the current market and pulled down the key factors that propel the growth of the Global Oculopharyngeal Muscular Dystrophy (OPMD) market in the forecasted period.

https://ksusentinel.com/2021/05/05/global-oculopharyngeal-muscular-dystrophy-opmd-market-poised-to-reach-at-high-cagr-in-forecast-period-2019-to-2028/

Global Oculopharyngeal Muscular Dystrophy (OPMD) Market Poised to Reach at High CAGR in Forecast Period 2019 to 2028 – KSU | The Sentinel Newspaper

KSU | The Sentinel Newspaper

01 02 03 04 05

FOLLOW US

My Company

#Polls

Companies

Keywords

FOLLOW US

BioMarin News

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at the BofA Securities Healthcare Conference on May 12...

″ Get Sample Report Buy Now Enzyme Replacement Therapy Market research report is the new statistical

New Jersey, United States - The study is a professional and comprehensive assessment of the Lam

New Jersey, United States - The study is a professional and comprehensive assessment of the Acq

The study on global Hemophilia market, offers profound understandings about the Hemophilia market covering all the essential aspects of the market. The

The Global Lysosomal Storage Disorder Drugs Market is estimated to gain market growth in the upcoming forecasted years. An influential Lysosomal Storage

Global “Hemophilia Treatment Market Report” Research Report 2022 - 2028 contains a thorough examinat

New Jersey, United States - The Acquired Hemophilia Treatment Market report is the ultimate too

Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

/PRNewswire/ -- On the heels of World Hemophilia Day, Believe Limited today announced a continuation of its exclusive partnership with BioMarin Pharmaceutical...

If history is any guide, there may be trouble ahead for shares of Biomarin Pharmaceutical (NASDAQ:BMRN). A so-called “death cross” has formed on its chart and, not surprisingly, this could be bearish for the stock.

The Gaucher Disease Treatment Market Report Forcast to 2022-2028 offers an in-depth analysis of driv

New Research: Global Duchenne Muscular Dystrophy Market 2026 Industry Specifications and Outlook 2021| PTC Therapeutics, Sarepta Therapeutics, Bristol-Myers Squibb, ITALFARMACO, BioMarin Brockville Observer

Covid-19 impact on Hemophilia Treatment Market Future Outlook of Statistics on Industry Growth till 2026| CSL Behring, Baxalta, Pfizer Inc, BioMarin, Bayer Healthcare, Biogen – Clark County Blog Clark County Blog

The Lipoid Proteinosis Drug Market research report analyzes the current as well as future aspects of the industry & presents leading regions, growth trends & strategies of the key players which is bound to impact the global Lipoid Proteinosis Drug industry share in various end-use applications.

OPEN IN APP